This conserved lipid acyltransferase has many re-entrant segments but only one true TM helix. Most closely related to bacterial acyltransferases.. Heavily expanded in kinetoplastids for unknown reasons. Localization: ER (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 27 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 28 |
NetGPI | no | yes: 0, no: 28 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 23 |
GO:0110165 | cellular anatomical entity | 1 | 23 |
Related structures:
AlphaFold database: A4H419
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 4 |
GO:0006644 | phospholipid metabolic process | 4 | 4 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 4 |
GO:0006654 | phosphatidic acid biosynthetic process | 6 | 4 |
GO:0006793 | phosphorus metabolic process | 3 | 4 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 4 |
GO:0008152 | metabolic process | 1 | 4 |
GO:0008610 | lipid biosynthetic process | 4 | 4 |
GO:0008654 | phospholipid biosynthetic process | 5 | 4 |
GO:0009058 | biosynthetic process | 2 | 4 |
GO:0009987 | cellular process | 1 | 4 |
GO:0019637 | organophosphate metabolic process | 3 | 4 |
GO:0044237 | cellular metabolic process | 2 | 4 |
GO:0044238 | primary metabolic process | 2 | 4 |
GO:0044249 | cellular biosynthetic process | 3 | 4 |
GO:0044255 | cellular lipid metabolic process | 3 | 4 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 4 |
GO:0046473 | phosphatidic acid metabolic process | 6 | 4 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 4 |
GO:0046486 | glycerolipid metabolic process | 4 | 4 |
GO:0071704 | organic substance metabolic process | 2 | 4 |
GO:0090407 | organophosphate biosynthetic process | 4 | 4 |
GO:1901576 | organic substance biosynthetic process | 3 | 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 29 |
GO:0016740 | transferase activity | 2 | 29 |
GO:0016746 | acyltransferase activity | 3 | 29 |
GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity | 7 | 5 |
GO:0008374 | O-acyltransferase activity | 5 | 5 |
GO:0016411 | acylglycerol O-acyltransferase activity | 6 | 5 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 5 |
GO:0042171 | lysophosphatidic acid acyltransferase activity | 6 | 5 |
GO:0071617 | lysophospholipid acyltransferase activity | 5 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 157 | 163 | PF00089 | 0.535 |
CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.546 |
CLV_NRD_NRD_1 | 23 | 25 | PF00675 | 0.312 |
CLV_NRD_NRD_1 | 306 | 308 | PF00675 | 0.607 |
CLV_PCSK_FUR_1 | 304 | 308 | PF00082 | 0.688 |
CLV_PCSK_KEX2_1 | 23 | 25 | PF00082 | 0.295 |
CLV_PCSK_KEX2_1 | 283 | 285 | PF00082 | 0.541 |
CLV_PCSK_KEX2_1 | 304 | 306 | PF00082 | 0.644 |
CLV_PCSK_PC1ET2_1 | 283 | 285 | PF00082 | 0.541 |
CLV_PCSK_SKI1_1 | 135 | 139 | PF00082 | 0.509 |
CLV_PCSK_SKI1_1 | 319 | 323 | PF00082 | 0.716 |
DOC_CKS1_1 | 130 | 135 | PF01111 | 0.269 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 35 | 44 | PF00134 | 0.182 |
DOC_MAPK_DCC_7 | 68 | 76 | PF00069 | 0.360 |
DOC_MAPK_gen_1 | 23 | 30 | PF00069 | 0.517 |
DOC_MAPK_MEF2A_6 | 210 | 218 | PF00069 | 0.304 |
DOC_MAPK_MEF2A_6 | 23 | 30 | PF00069 | 0.521 |
DOC_MAPK_MEF2A_6 | 32 | 40 | PF00069 | 0.476 |
DOC_MAPK_MEF2A_6 | 68 | 76 | PF00069 | 0.348 |
DOC_PP1_RVXF_1 | 30 | 36 | PF00149 | 0.430 |
DOC_PP1_RVXF_1 | 77 | 84 | PF00149 | 0.316 |
DOC_PP1_RVXF_1 | 89 | 95 | PF00149 | 0.321 |
DOC_PP1_RVXF_1 | 99 | 106 | PF00149 | 0.369 |
DOC_PP2B_LxvP_1 | 324 | 327 | PF13499 | 0.342 |
DOC_PP2B_LxvP_1 | 59 | 62 | PF13499 | 0.411 |
DOC_WW_Pin1_4 | 129 | 134 | PF00397 | 0.311 |
LIG_14-3-3_CanoR_1 | 101 | 106 | PF00244 | 0.321 |
LIG_14-3-3_CanoR_1 | 307 | 317 | PF00244 | 0.408 |
LIG_14-3-3_CanoR_1 | 79 | 84 | PF00244 | 0.401 |
LIG_Actin_WH2_2 | 122 | 137 | PF00022 | 0.374 |
LIG_APCC_ABBA_1 | 200 | 205 | PF00400 | 0.310 |
LIG_FHA_1 | 138 | 144 | PF00498 | 0.294 |
LIG_FHA_1 | 242 | 248 | PF00498 | 0.361 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.333 |
LIG_FHA_1 | 5 | 11 | PF00498 | 0.262 |
LIG_FHA_1 | 61 | 67 | PF00498 | 0.297 |
LIG_GBD_Chelix_1 | 277 | 285 | PF00786 | 0.563 |
LIG_LIR_Apic_2 | 80 | 86 | PF02991 | 0.238 |
LIG_LIR_Gen_1 | 124 | 134 | PF02991 | 0.289 |
LIG_LIR_Gen_1 | 222 | 231 | PF02991 | 0.263 |
LIG_LIR_Gen_1 | 257 | 267 | PF02991 | 0.351 |
LIG_LIR_Nem_3 | 104 | 108 | PF02991 | 0.287 |
LIG_LIR_Nem_3 | 120 | 126 | PF02991 | 0.296 |
LIG_LIR_Nem_3 | 217 | 223 | PF02991 | 0.280 |
LIG_LIR_Nem_3 | 232 | 237 | PF02991 | 0.280 |
LIG_LIR_Nem_3 | 257 | 262 | PF02991 | 0.349 |
LIG_PCNA_PIPBox_1 | 187 | 196 | PF02747 | 0.196 |
LIG_PDZ_Class_2 | 332 | 337 | PF00595 | 0.361 |
LIG_Pex14_2 | 154 | 158 | PF04695 | 0.326 |
LIG_Pex14_2 | 164 | 168 | PF04695 | 0.301 |
LIG_PTB_Apo_2 | 109 | 116 | PF02174 | 0.272 |
LIG_PTB_Phospho_1 | 109 | 115 | PF10480 | 0.183 |
LIG_SH2_CRK | 126 | 130 | PF00017 | 0.374 |
LIG_SH2_CRK | 251 | 255 | PF00017 | 0.425 |
LIG_SH2_PTP2 | 18 | 21 | PF00017 | 0.249 |
LIG_SH2_PTP2 | 259 | 262 | PF00017 | 0.381 |
LIG_SH2_STAP1 | 126 | 130 | PF00017 | 0.367 |
LIG_SH2_STAT5 | 115 | 118 | PF00017 | 0.225 |
LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.305 |
LIG_SH2_STAT5 | 259 | 262 | PF00017 | 0.331 |
LIG_SH3_3 | 127 | 133 | PF00018 | 0.398 |
LIG_SUMO_SIM_par_1 | 235 | 242 | PF11976 | 0.365 |
LIG_SUMO_SIM_par_1 | 6 | 12 | PF11976 | 0.222 |
LIG_TRAF2_1 | 298 | 301 | PF00917 | 0.315 |
LIG_TYR_ITIM | 16 | 21 | PF00017 | 0.379 |
LIG_WRC_WIRS_1 | 215 | 220 | PF05994 | 0.284 |
MOD_CDK_SPxK_1 | 129 | 135 | PF00069 | 0.335 |
MOD_CK1_1 | 172 | 178 | PF00069 | 0.323 |
MOD_CK1_1 | 238 | 244 | PF00069 | 0.410 |
MOD_CK1_1 | 273 | 279 | PF00069 | 0.396 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.488 |
MOD_CK1_1 | 47 | 53 | PF00069 | 0.370 |
MOD_GlcNHglycan | 171 | 174 | PF01048 | 0.591 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.337 |
MOD_GSK3_1 | 139 | 146 | PF00069 | 0.304 |
MOD_GSK3_1 | 313 | 320 | PF00069 | 0.390 |
MOD_LATS_1 | 167 | 173 | PF00433 | 0.196 |
MOD_N-GLC_1 | 117 | 122 | PF02516 | 0.466 |
MOD_N-GLC_1 | 4 | 9 | PF02516 | 0.182 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.457 |
MOD_NEK2_1 | 143 | 148 | PF00069 | 0.300 |
MOD_NEK2_1 | 196 | 201 | PF00069 | 0.317 |
MOD_PKA_2 | 270 | 276 | PF00069 | 0.286 |
MOD_Plk_1 | 117 | 123 | PF00069 | 0.266 |
MOD_Plk_1 | 241 | 247 | PF00069 | 0.351 |
MOD_Plk_1 | 4 | 10 | PF00069 | 0.182 |
MOD_Plk_4 | 118 | 124 | PF00069 | 0.276 |
MOD_Plk_4 | 222 | 228 | PF00069 | 0.336 |
MOD_Plk_4 | 313 | 319 | PF00069 | 0.317 |
MOD_Plk_4 | 4 | 10 | PF00069 | 0.472 |
MOD_Plk_4 | 79 | 85 | PF00069 | 0.400 |
MOD_ProDKin_1 | 129 | 135 | PF00069 | 0.311 |
MOD_SUMO_rev_2 | 311 | 316 | PF00179 | 0.362 |
TRG_ENDOCYTIC_2 | 126 | 129 | PF00928 | 0.385 |
TRG_ENDOCYTIC_2 | 18 | 21 | PF00928 | 0.376 |
TRG_ENDOCYTIC_2 | 220 | 223 | PF00928 | 0.310 |
TRG_ENDOCYTIC_2 | 234 | 237 | PF00928 | 0.269 |
TRG_ENDOCYTIC_2 | 251 | 254 | PF00928 | 0.363 |
TRG_ENDOCYTIC_2 | 259 | 262 | PF00928 | 0.348 |
TRG_ER_diArg_1 | 23 | 25 | PF00400 | 0.556 |
TRG_ER_diArg_1 | 304 | 307 | PF00400 | 0.431 |
TRG_ER_diArg_1 | 88 | 91 | PF00400 | 0.239 |
TRG_Pf-PMV_PEXEL_1 | 307 | 312 | PF00026 | 0.600 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P455 | Leptomonas seymouri | 55% | 99% |
A0A0N1HTP4 | Leptomonas seymouri | 58% | 100% |
A0A0N1I6V1 | Leptomonas seymouri | 35% | 100% |
A0A0S4IQ05 | Bodo saltans | 30% | 99% |
A0A0S4IR22 | Bodo saltans | 41% | 100% |
A0A0S4JRB2 | Bodo saltans | 33% | 100% |
A0A1X0P9F0 | Trypanosomatidae | 35% | 100% |
A0A3R7NKA0 | Trypanosoma rangeli | 36% | 100% |
A0A3S5H5E4 | Leishmania donovani | 66% | 78% |
A0A3S5H7L8 | Leishmania donovani | 34% | 100% |
A0A3S7WNW6 | Leishmania donovani | 56% | 95% |
A4H418 | Leishmania braziliensis | 87% | 100% |
A4H420 | Leishmania braziliensis | 75% | 95% |
A4HHM7 | Leishmania braziliensis | 35% | 100% |
A4HSA1 | Leishmania infantum | 65% | 100% |
A4HSA2 | Leishmania infantum | 56% | 95% |
A4I4U1 | Leishmania infantum | 32% | 100% |
A4I4U2 | Leishmania infantum | 34% | 100% |
C9ZLI8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 100% |
E9AE89 | Leishmania major | 32% | 100% |
E9AE90 | Leishmania major | 34% | 100% |
E9AK86 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 60% | 100% |
E9ALJ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 100% |
E9B2X4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
Q9NF90 | Leishmania major | 57% | 100% |
Q9NF91 | Leishmania major | 68% | 100% |
V5C201 | Trypanosoma cruzi | 32% | 100% |